|
Prostate cancer cases
Case 1: Malignant prostate pathology
Name: Eber Paiva
Age: 67 years old
Country: Uruguay
Reason of consultation:
10/5/2001 Consults because of polaquiury and disury.
Has UAR done which makes him been catheterized. He is
treated with pelvic anti-
inflammatories and does not improve. This symptomatology
was present since six months ago. The episode of the
UAR motivated his consultation.
Personal antecedents: No personal antecedents to remark.
Family antecedents: Mother deceased because of a rectum
AC.
Present disease’s antecedents:
He begins six months ago with polaquiury and disury
which needs the mentioned treatment to be performed.
Rectum tactum performed, prostate compatible with a
IV grade hypertrophy. (see page 17).
Biopsy by trans-rectum ultrasonography that shows well
differentiated prostate adenocarcinoma. Gleason 5, PSA
14,94 (see page 18).
GREEN SAP initiated on November 3rd., 2001, 40 drops
3 times per day.
PSA after 30 days: 8,21.
11/23/2001: Computerized tomography (see page 23): Prostate
size very increased and its density is heterogenic,
which can correspond to a necrosis in its interior.
It disfigures the blade’s floor but does not seem
to infiltrate it.
It is decided to increase the medicament to 40 drops
4 times per day. He improves the urination disorders
(urination stinging) and testicle pain.
Disease evolution: On the 01/06/2002 has PSA tested
which result is: 6.74 ng/ml. (see page 25). On the 08/22/2002
Total PSA 0.83 ng/ml. (see page 27). It is remarkable
that the patient also received, as we advised conventional
therapy, hormonal and radiant, being at the present
moment in clinic cure following with the ingestion of
our medication.
Released patient, ingests the medicament for one month
yearly in a dosage of 30 drops per day.
Conclusions: 67 years old, with no personal antecedents
to mark, suffers an urine acute retention. The biopsy
by trans-rectal ultrasonography shows a Prostate Adenocarcinoma
well differentiated Gleason 5, PSA 14.94. GREEN SAP
treatment is initiated on November 3rd., 2001, 40 drops
3 times per day. He quickly improves his urinary disorders
and testicle pain that grieved him.
He reaches clinic cure and release thanks to the use
of GREEN SAP, which has an acknowledged efficacy in
Prostate cancer.
GREEN SAP is a medicament of proved efficacy in this
pathology, demonstrated along the years and the empiric
experience. It is evident that GREEN SAP avoided more
significant damages in the patient and we can say that
it is a medicament for which this patient lives thankful
for having eliminated his illness.
Case 2: Malignant prostate pathology:
Mr. Héctor Tanco.
Name: Héctor Tanco
Age: 66 years old
Country: Argentina
Reason of consultation:
12/26/2000 Consults because of polaquiury with no other
symptoms. Normal urine.
Personal antecedents: Hypertension, treated with hyposodic
diet although he does not attach to it regularly.
Smoker until 30 years ago. No alcohol. Apendicectomized
and amigdalectomized, asthma until 22 years old.
Family antecedents: None to remark.
Present disease antecedents:
Begins with polaquiury. Studied with PSA showed figures
of 84.5 on the 03/05/2001 which motivated a more exhausting
study (see page 35).
04/04/2001- Has ultrasonography done which show images
compatible with prostate of 38 mm. x 36 mm. and an approximate
weight of 28 g., slightly post-urinary residue with
no pathological significance, blade wall of normal thickness,
with no endoluminal projections, joining free blade-urethers.
Bilateral renal ultrasonography: both kidneys are of
normal shape and size, with parenquimo-sinusal relation
conserved. They are not observed neither signs of hydronefrosis
nor images that could correspond to lithyasis (see page
33).
Prostate Biopsy Punction under trans-rectal ultrasonographic
control. Images compatibles with: Prostate of 38x41x31
mm. which shows an approximately weight of 34 g. The
specific prostate antigen for that weight would be 4
ng/ml. Cystic image in retro-uretheral central zone,
seminal vesicles symmetric (see page 43).
Pathological Anatomy: showed a well differentiated Prostate
Adenocarcinoma. Gleason Score 5 (3+2). It is a bilateral
carcinoma, the compromise is similar in both sides and
of a 50 %. Date of the result: 05/15/2001.
Total bone centellography: Date 06/06/2001 in the bone
scan performed no pathologic hyper-concentration areas
of the isotope are seen (see page 47).
Abdominal and pelvic Computerized Axial Tomography:
The liver conserves its habitual morphology and density,
its structure is homogeneous, there is no dilatation
of the bilious way, the bilious vesicle content is homogeneous
by this method. Spleen, pancreas, kidneys and adrenal
conserved. At the pelvic area an increased size of the
prostate is observed with of the blade floor, the blade
shows its walls slightly thickened. No lymph nodes retro
peritoneal iliac or inguinal are observed.
Disease evolution: A treatment with gosereline, 3,6
injectable, monthly, is installed, and bicalutamide
50 mg. per day. As a definitive pretreatment is installed
B.A.T.
We indicate 50 drops of the medicament, sublingually,
every 6 hours.
06/06/2001 A bone centellography is done, showing that
in the bone scan performed no areas of pathological
hyper-concentration of the isotope are seen.
04/03/2002 Asymptomatic, increased to 60 drops every
6 hours.
Normalization of his free PSA.
Patient who begins his disease in stage T 2c N0 M0.
He took the medicament during a year, at the present
moment he is at clinic cure, taking 30 drops per day
during one month, one month per year. Patient on release.
66 years old, hypertension, treated with hypo-sodic
diet, carrying a prostate differentiated adenocarcinoma,
Gleason Score 5 (3+2), with similar compromise of both
sides of a 50 % (05/15/2001).
Treated with gosereline 3,6 injectable during a month
and with bicalutamide 50 mg. per day. A total androgenic
blockade is performed, definitive pretreatment.
He receives the medicament 50 drops sublingually every
6 hours; he reaches the cure due to GREEN SAP which
was the medicament he most received.
There is normalization of the biochemical parameters
which are beneath normal limits.
The patient leads a life with an excellent quality thanks
to the medicament.
GREEN SAP has an excellent action against prostate cancer
and has achieved that this patient leads a complete
life and has eliminated his neoplasy thanks to this
medicament. GREEN SAP has returned to him total functionality
and changed his life, due to its efficacy empirically
proved and of first level in prostate cancer.
Case 3: Malignant prostate pathology:
Mr. Raúl Smith.
Name: Raúl Smith Belgrave
Age: 77 years old
Country: Cuba
Reason of consultation:
Night urine and weak urine flow.
Personal antecedents:
Mesenteric thrombosis in January,1995. He went under
surgery and is evolutioning without difficulty.
Family antecedents: With no antecedents to remark.
Present Disease Antecedents:
Because of the night urine and weak urine flow was attended
by an urologist who found at the rectal digital exam
a prostate size increased and hardened of woody consistence,
therefore indicating the following complementary exams
which showed the following results:
01/11/2002: Hemoglobin 134 g/l, Eritro 14 mm/h, Creatinine
98 mmol/l.
Prostate ultrasonography: Bladder almost empty, anyway
prostate size globally increased and heterogeneous,
which measures 55x41. Superior hemi-abdomen ultrasonography:
fat liver, no nodular lesion, no other alterations.
Bone gammagraphy: Nuclear bone scan where increased
accumulation of the radio-pharmaco can be seen in the
lumbar vertebral column (L5) and reduced accumulation
in both sacroiliac joints.
Prostate biopsy 01/11/2002: Moderately differentiated
prostate adenocarcinoma, Gleason 6, PSA 88,1 ng/l. It
was concluded that the patient presents a moderately
differentiated prostate adenocarcinoma not metastasic
and he was indicated to begin with Androcur 2 tablets
per day. The month after having begun the treatment
PSA is repeated 02/12/2002: from 88 ng/l to 21,4 ng/l.
Besides the patient experiments a notable improvement
related to the night urine previously mentioned.
Disease evolution:
It was not possible to follow through the PSA as there
are no reactives in the country. But the imagenologic
studies were repeated on the 07/04/2002 and the gammagraphy
showed the following inform:
Nuclear bone scan shows larger accumulation of the radio-pharmaco
on the fifth lumbar vertebra subjective of an increased
osteoblastic activity at that level.
It is suggested a conventional radiological study to
discard bone degenerative process, in the rest of the
skeleton no other pathological captures can be visualized.
Now the patient refers to present only pain in the hip
joint.
12/09/2003 Another PSA is done and is of 12 ng/l and
the hip joint pain has frankly improved, he goes on
with the treatment with the medicament in a dosage of
40 drops 3 times per day.
On the 02/26/2003 another PSA is done which is of 7,4
ng/l, the night urine has improved remarkably, he is
in a good general state of health. He did not have loss
of weight. He keeps a good appetite.
03/07/2003 He is reevaluated by oncology and urology
and is reported as clinically cured.
All the complementary exams are within normal parameters.
(see Some e-mails received page 159).
Patient on release clinically cured.
Conclusions: Patient of 77 years old proceeding from
Cuba, with personal antecedents of mesenteric thrombosis
in January 1995, who consults due to a low urinary syndrome,
being explored with rectal tactum which showed prostate
increased in size, hardened, of woody consistence. Prostate
ultrasonography, bladder almost empty, though prostate
globally increased in size, and heterogeneous, which
measures 55 mm x 41 mm. By ultrasonography there is
either no liver compromise nor other abdominal alterations.
Bone centellography with increased accumulation of the
radio-pharmac in lumbar vertebral column (L5) and reduction
of it in both sacroiliac joints. The 01/11/2002 biopsy
showed Moderately Differentiated Prostate Adenocarcinoma,
Gleason 6, PSA 88,1 ng/l. He was indicated Androcur,
2 tablets per day and the PSA lows to 21,4 ng/l.
On the 12/09/2003: PSA in 12 ng/l, frank hip joint pain
improvement, receiving a dosage of 40 drops 3 times
per day. Patient on urology and oncology release, with
last PSA of 7,4 ng/l. Good general state, no weight
loss and good appetite. All the complementary exams
are within normal parameters. There is no doubt that
the benefic effect of GREEN SAP on the prostate cancer,
has manifested totally, conducting to the clinic cure
of the patient, as well as his doctor daughter tells
us by e-mail.
This patient achieved the cure of his pathology thanks
to the use of GREEN SAP, that has a proven first level
efficacy in prostate cancers, as well as in lots of
others. It supports this testimony the fact that this
patient’s daughter is a colleague who worked in
the National Oncology Institute of Cuba and actually
is working in Luanda – Angola. Once again GREEN
SAP contributes to the eradication of a malignant pathology
and to the patient having a worthy life and disease
free.
Case 4: Glandular hyperplasia
with atypical focuses with PIN III
Name: Luis Mohana
Age: 72 years old
Country: Argentina
Reason of consultation:
05/02/2002 The patient’s wife consults, he presents
prostate tumor.
Personal antecedents:
No personal antecedents to remark.
Family antecedents: None to remark.
Present disease antecedents:
Treated due to bladder polyps, with multiple explorations.
In one of them a prostate increased in size is discovered,
having the patient a normal PSA. In the first Pathological
Anatomy can be seen various fragments of prostate tissue
with glandular hyperplasia, ectasy, chronic inflammation
and multiple areas of PIN III with acinar hyperplasia,
(see page 57). Results: low molecular weight queratine
positive 95 % and (++). High molecular weight queratine
positive in the area of atypical proliferation. PIN
III (Diagnosis: glandular hyperplasia with micro-areas
of PIN III).
Note: No total loss of basal layer is observed in these
areas.
It is indicated control and treatment in Oncology Urology
center in Buenos Aires. A biopsy is solicited 6 months
from now on and PSA 3 months from now on. It is indicated
to begin with the medicament with 30 drops 4 times per
day sublingually.
Disease evolution:
06/05/2002 – Consults again with his wife. He
refers asymptomatic, has a PSA to be done the 07/03/2002.
The PSA levels are on increase but always within normal
limits.
03/07/2002 PSA – 2,1 ng/ml
03/26/2002 PSA – 2,54 ng/ml
We keep in touch by e-mail or telephone. He accomplishes
the treatment with the medicament precisely and the
process keeps localized. As we do not see the patient
we cannot have the perception that gives clinic exploration,
anyway, at the present moment, the patient is within
normal parameters.
07/10/2002 – Telephone communication with the
patient who refers his 07/03/2002 PSA as of 3.09 ng/ml,
that he is asymptomatic and his general state is good.
He keeps on receiving 30 drops 4 times per day sublingually;
we increase the dosage to 45 drops 4 times per day due
to the slight increase of the PSA.
08/07/2002 A telephone communication with the patient
was made, where he refers being asymptomatic, with good
spirit, and performing all his daily activities. He
considers that the intake of the drops has benefited
him remarkably, opinion we share. Next control in March,
2003. Clinically stable patient. He goes on with the
medicament with 45 drops 4 times per day.
03/25/2003 Telephone communication with the patient
in what he communicates us he is in excellent state
of health performing his daily activities and with no
kind of problem. He send us via fax the last PSA made
on the 03/14/2003 with a value of 3,56 ng/ml. (see page
59). Also he sends a pelvic ultrasonography with normal
results (see page 60). Patient on release, at present
on clinic cure. It is indicated a maintenance dosage
of 30 drops per day during a month, once a year.
Conclusions: Patient with malignant prostate pathology
of 72 years old proceeding from Argentina, consulting
his wife and referring to us a prostate tumoration.
Treated due to bladder polyps, in one of them is discovered
the prostate was increased in size, having a normal
PSA.
The pathological anatomy shows glandular hyperplasia
with micro-areas of PIN III, and begins treatment with
the medicament on May 3rd., 2002.
Beginning with 30 drops, 4 times per day sublingually.
Evolution towards an improvement, keeping always the
PSA within normal values. Effect we attribute to the
GREEN SAP. Patient who at present we can consider cured
(not with the criteria of 5 years, international criteria)
thanks to the use of GREEN SAP, which once again has
shown its nobility as an anti-neoplasic medicament allowing
the patient to be in a good state of health performing
the daily activities that any person can do.
Case 5: Malignant prostate pathology
Name: Pablo Cordero
Age: 88 years old
Country: Panama
Reason of consultation:
05/25/2002 Acute urine retention
Personal Antecedents:
Gonartritis; hypo-acusia.
Family antecedents: None to remark.
Present disease antecedents:
In January, 2002, due to an acute urine retention, after
being examined he was given the diagnosis of prostate
cancer, he had a bladder endoscopy made towards the
end of March, resulting positive and was indicated Flutamide
one tablet 3 times per day. He was suggested an orchectomy,
but his family prefers alternative therapy. He looses
weight. Anemic, with no pelvic pain, with bladder catheter.
He underwent a prostate biopsy punction. Anatomy pathology
Diagnosis: A. Prostate, right lobe (biopsy), moderately
differentiated adenocarcinoma, Gleason 3+4=7 which compromises
approximately 30 % of the sample, with no peri-neural
invasion.
There’s a PIN III area of high grade, areas of
lympho-vascular permeation are observed. B. Prostate,
left lobe (biopsy), moderately differentiated adenocarcinoma
Gleason 3+4=7 which compromises approximately 20 % of
the sample.
No peri-neural or vascular invasion is observed.
A month later bone centellography shows compromise,
not defining in which bone.
Disease evolution: They decide to use our medicament.
The patient feels well and the catheter was retired.
In the 4th. month of treatment with the medicament he
is urinating normally.
On February 11th., 2003, underwent a surgery due to
intestinal occlusion caused by adherences of an old
appendicitis surgery. He was grave and stayed in hospital
for 36 days.
Also due to a pneumonia because of a hospital bacteria,
but he is recovering satisfactorily.
He had a rectal exam done and a pelvic and abdominal
computerized tomography. In the rectal exam a prostate
increased in size but soft was found, as a bubble and
not woody. He did not show pain at the tactum, the CAT
showed a somehow big prostate. The surgeon informed
that in the operation area the intestines were metastases
free, only some necrosis of the thin intestine due to
adherence was found.
He changes doctor and consults a urology oncologist,
who did not know his case and found a prostate with
the size of a plump.
The prostate was found to be of soft consistence as
rubber and had a little protuberance also soft. He was
surprised by the fact that previously he had been diagnosed
as advanced prostate cancer. The doctor saw the biopsy
and confessed that if it wasn’t for it he wouldn’t
have believed it was the same patient.
A bottle of the medicament he was taking is shown to
the doctor. He concluded that this medicament, which
was the only thing he was taking, must have improved
his cancer. Anyway he ordered some laboratory exams
and “X” rays, he recommended to go on taking
the medicament.
The patient is asymptomatic, in clinic cure and on release.
(see Some E-mails received, page 159).
Conclusions on anti-tumor GREEN SAP action on malignant
prostate neoplasies.
Evidently, as for the collected experience, a benefic
effect of GREEN SAP on prostate neoplasies is found,
which is demonstrated by normalizing or reducing the
PSA, causing a loss of size of the tumors evident either
by rectal tactum or by trans-rectal ultrasonographies
explorations, as well as on its consistence which goes
from rocky to woody and from woody to a normal prostate
consistence. The particular histological structure of
the prostate can be in the genesis of this interaction
which is hurtful to the tumor. Probably by a antiangiogenic
mechanism the neo-vascularization of the tumor is prevented,
depriving it of essential nourishing factors for its
development. This development has lost control, the
cells have lost contact inhibition to proliferate.
GREEN SAP would act too at tumor cell’s nucleus
level, affecting its DNA and preventing the malignant
cell’s proliferation; altering the order of the
DNA bases and provoking a molecular “disorder”
which would lead to the apoptosis, that is tumor cell
death not only at the moment of GREEN SAP action but
also afterwards, generating a chain effect that evolutes
to the tumor death induced by GREEN SAP.
This is maybe the reason why we find samples of prostatectomies
with important intra-tumor necrosis and hemorrhages
in their way to resolve or organizing; this observation
would not correspond so much with the conventional hormonal
treatment generally used.
It was also observed that GREEN SAP; prevents the creation
of new tumor clones that escape to the body’s
control and provoke early metastasis moreover on the
bone substance, prostate metastases have avidity for
bones.
Therefore GREEN SAP has a protective action on the bones
preventing this body sector’s colonization by
the disease, we observed osteoblastic lesions treated
with GREEN SAP that set back and are eliminated by the
organic depurator systems, provoking a removal and mobilization
of the accumulated substance in the skeleton or particular
areas of it.
The bone centellography exploration allows to appreciate
the differences among treatments before and after the
GREEN SAP.
The hormonal traditional therapy has the risk of provoking
thrombotic pathology.
This is another effect we see that does not occur with
GREEN SAP, when a conventional treatment plus GREEN
SAP is faced, what leads to the patient’s benefit
as it frees him of thrombosis of the lower limbs and
other economy’s areas.
Many times this can be the event that provokes a lung
thrombo-embolism, and this can lead to a very characteristic
episode which can lead towards the patient’s death.
Knowing the fact that lung thrombo-embolism is diagnosed
by perfusion-inhalation centellography, in order to
appreciate the lung area that ventilates and therefore
the affected one, we can affirm that in conventional-GREEN
SAP mixed treatments, we did not observed it so it does
not occur in our casuistic.
|
